ADRENALIGNE

{
  "events": [
    {
      "kind": "fusion_share_issue",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "share_emission": {
        "agio_eur": null,
        "share_form": null,
        "share_class": null,
        "n_new_shares": 186,
        "with_new_shares": true,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": 186,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": "convert_to_distributable"
    }
  ],
  "notary": {
    "name": "Jean S\u00E9bastien Lambin",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Mettet",
    "is_associated": false
  },
  "act_meta": {
    "language": "mixed",
    "pub_date": "2025-07-17",
    "filing_date": null,
    "act_kind_objet": "Objet de l\u0027acte:"
  },
  "decision": {
    "body": "assembl\u00E9e_generale_extraordinaire",
    "act_date": "2025-07-27",
    "unanimous": null,
    "under_authorized_capital": false,
    "underlying_resolution_date": "2025-07-27"
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0810.537.839",
    "name_full": "ADRENALIGNE",
    "legal_form": "Soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e",
    "is_foreign_registered": false
  },
  "publication_proxy": {
    "kind": "none",
    "org_kbo": null,
    "org_name": null,
    "person_name": null,
    "org_rep_person_name": null,
    "person_role_at_subject": null
  },
  "co_filed_documents": [
    "expedition",
    "procuration"
  ],
  "shareholders_after": [],
  "share_classes_after": []
}

{
  "stage": "proposal",
  "notary": {
    "name": null,
    "firm_city": null,
    "firm_name": null,
    "office_city": null,
    "is_associated": false
  },
  "act_meta": {
    "language": "mixed",
    "pub_date": "2025-04-02",
    "filing_date": "2025-03-26",
    "act_kind_objet": "Projet d\u0027op\u00E9ration assimil\u00E9e \u00E0 une fusion par absorption"
  },
  "decision": {
    "body": null,
    "act_date": null,
    "unanimous": null
  },
  "conversion": null,
  "detected_kind": "merger_absorption",
  "report_waiver": null,
  "restructuring": {
    "parties": [
      {
        "kbo": null,
        "name": "ADRENALIGNE",
        "role": "acquiring",
        "address": "Avenue des Jardinets 2- 1170 Watermael-Boitsfort",
        "is_foreign": false,
        "legal_form": "S.R.L.",
        "is_new_company": false,
        "jurisdiction_country": "BE"
      },
      {
        "kbo": "0447.279.371",
        "name": "PHILIPPE TOME",
        "role": "absorbed",
        "address": "Avenue des Jardinets 2- 1170 Watermael-Boitsfort",
        "is_foreign": false,
        "legal_form": "S.A.",
        "is_new_company": false,
        "jurisdiction_country": "BE"
      }
    ],
    "exchange_ratio": null,
    "legal_articles": [
      "12:2,al 1er",
      "12:7",
      "12:50"
    ],
    "is_cross_border": false,
    "is_silent_merger": false,
    "balance_basis_date": "2024-12-31",
    "exchange_ratio_text": null,
    "new_shares_issued_n": null,
    "real_estate_included": false,
    "patrimony_description": "Tout le patrimoine, y compris les droits et les obligations, de la SA PHILIPPE TOME sera transf\u00E9r\u00E9 \u00E0 la SRL ADRENALIGNE.",
    "equity_transferred_eur": null,
    "accounting_effective_date": "2025-01-01"
  },
  "subject_company": {
    "kbo": "0810.537.839",
    "name_full": "ADRENALIGNE",
    "legal_form": "Soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 priv\u00E9e"
  },
  "publication_proxy": {
    "kind": "org",
    "org_kbo": "0431.475.103",
    "org_name": "PME-Conseils SA",
    "person_name": null,
    "org_rep_person_name": "Christophe SOMERS"
  },
  "summary_narrative": "La soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e ADRENALIGNE et la soci\u00E9t\u00E9 anonyme PHILIPPE TOME ont l\u0027intention de proc\u00E9der \u00E0 une op\u00E9ration assimil\u00E9e \u00E0 une fusion par absorption. Par cette op\u00E9ration, tout le patrimoine de la SA PHILIPPE TOME sera transf\u00E9r\u00E9 \u00E0 la SRL ADRENALIGNE, suite \u00E0 une dissolution sans liquidation de la SA PHILIPPE TOME.",
  "co_filed_documents": [],
  "detected_real_type": "fusion_proposal",
  "referenced_correction": null,
  "should_reroute_to_category": null
}